Xtant Medical Holdings XTNT Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss.
The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xtant Medical Holdings's allowance for doubtful accounts receivable (current)?
- Xtant Medical Holdings (XTNT) reported allowance for doubtful accounts receivable (current) of $2.12M in Q1 2026.
- How has Xtant Medical Holdings's allowance for doubtful accounts receivable (current) changed year-over-year?
- Xtant Medical Holdings's allowance for doubtful accounts receivable (current) increased by 24.0% year-over-year, from $1.71M to $2.12M.
- What is the long-term trend for Xtant Medical Holdings's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Xtant Medical Holdings's allowance for doubtful accounts receivable (current) has grown at a 27.1% compound annual growth rate (CAGR), from $653K to $2.17M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.